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Letter to Editor 
We thank the readers for their interest in our article(1). 
 
With regards to the request for correlation with office and ambulatory blood 
pressure readings, these data are provided in the manuscript; end-diastolic wall 
thickness (EDWT) correlated with office SBP (R=0.43, P<.001) and office DBP (R=0.32, 
P<.005) but did not correlate with ABPM SBP (R=0.24, P=.12), ABPM DBP (R=0.18, 
P=.27), or ABPM mean arterial pressure (R=0.18, P=.27). 
 
We agree that echocardiography is currently the imaging modality most frequently 
used to investigate subjects with arterial hypertension, but cardiovascular magnetic 
resonance imaging (CMR) has the potential to offer a ‘one-stop’ comprehensive 
assessment of subjects with hypertension, both to screen for secondary causes and 
identify end-target organ damage(2). 
 
We elected to perform CMR rather than echocardiography because of 1) its 
increased spatial resolution and tissue contrast and 2) the suboptimal imaging due to 
the relatively high prevalence of concomitant obesity in our cohort. We have not 
performed a direct comparison of echocardiographic and CMR findings but agree it 
would be interesting to perform such an analysis. 
 
We agree that left ventricular (LV) geometry is an interesting parameter. We provide 
data on absolute wall thickening relative to the LV end-diastolic diameter to correct 
for changes in LV cavity size. Absolute wall thickening is determined by both end-
diastolic wall thickness and radial strain. The proportional decrease in cavity size 
during systole is more closely determined by end-diastolic dimension than volume. 
Correction of 1-dimensional measurement (absolute wall thickening) by another 1-
dimensional measurement (diameter) intuitively makes more sense than by a 3-
dimensional measurement (volume). 
 
We provided information on longitudinal shortening, which is mathematically 
equivalent to longitudinal engineering strain (but with an opposite sign). We chose 
to calculate mid wall myocardial shortening instead of mean circumferential strain as 
there is a large strain gradient between the epicardium and endocardium. 
 
We agree the interaction between diffuse myocardial interstitial fibrosis and 
myocardial mechanics in hypertensive heart disease is an interesting area. Further to 
the study by Kuruvilla et al.(3), our group has shown that the prevalence and degree 
of LV fibrosis and central aortic distensibility vary amongst different hypertensive 
heart disease  LV phenotypes(4,5). We agree that such new insights are important in 
furthering our understanding of the pathophysiology of hypertensive heart disease 
and our appreciation of different potential aetiologies and drivers of the 
hypertensive state. Such insights should help us to tailor existing anti-hypertensive 
treatments more effectively and highlight potential substrate for new anti-
hypertensive strategies. 
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